Some of these novel drivers include neurotrophic receptor tyrosine kinases (NRTKs), neuregulin-1 (NRG1) gene fusions and rearranged during transfection (RET) gene fusions that are commonly observed in NSCLC cases. The gene discussed is RET; the disease is non-small cell lung carcinoma.